London's blue chip benchmark finished in the red on Tuesday, as the boost from promising early results from a Covid-19 vaccine trial conducted by Moderna...
Gervaise Heddle, Chief Executive Officer, exercised 17,500,000 shares in the company on the 18th May 2020 at a price of 0.70p. The Director now holds...
Gervaise Heddle, Chief Executive Officer, sold post-exercise 4,500,000 shares in the company on the 18th May 2020 at a price of 9.25p. The Director now...